What is LifeVantage?
LifeVantage Corporation operates at the nexus of biotechnology, nutritional science, and direct selling, specializing in the development and distribution of nutrigenomic products. The company's core philosophy centers on the science of nutrigenomics, exploring how nutrients and natural compounds can influence gene expression to enhance human health and longevity. LifeVantage formulates and markets a range of scientifically backed dietary supplements, nootropics, probiotics, weight management solutions, and personal care items, aiming to activate the bodys natural cellular health and resilience processes. Its market strategy emphasizes proprietary formulations and scientifically validated ingredients to stand out in the competitive wellness landscape.
How much funding has LifeVantage raised?
LifeVantage has raised a total of $11.1M across 2 funding rounds:
Debt
$1.1M
Debt
$10M
Debt (2007): $1.1M with participation from ASPENWOOD CAPITAL
Debt (2016): $10M led by Zions Bank
Key Investors in LifeVantage
Zions Bank
Zions Bank is a financial institution that likely provided debt financing, supporting LifeVantage's operational or expansionary capital needs.
ASPENWOOD CAPITAL
Aspenwood Capital, an investment banking firm specializing in capital raising for small-cap companies, has provided debt financing, indicating support for LifeVantage's financial structure and growth initiatives.
What's next for LifeVantage?
The recent major strategic investment indicates LifeVantage is likely in a growth or scaling phase, potentially looking to enhance its product development pipeline, expand its distribution channels, or further its research into nutrigenomic applications. The company's focus on scientific innovation and its established presence in the direct selling model suggest a strategic direction aimed at solidifying its market leadership and exploring new avenues for consumer health solutions.
See full LifeVantage company page
